- Home
- PSEC vs NEO Comparison
PSEC vs NEO Comparison
Compare PSEC & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PSEC | NEO |
|---|---|---|
| Founded | 2004 | 2001 |
| Country | United States | United States |
| Employees | 8 | N/A |
| Industry | Finance/Investors Services | Precision Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | PSEC | NEO |
|---|---|---|
| Price | $2.28 | $11.47 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | $2.50 | ★ $13.38 |
| AVG Volume (30 Days) | ★ 6.4M | 1.2M |
| Earning Date | 05-08-2026 | 04-28-2026 |
| Dividend Yield | ★ 20.07% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $10.63 |
| Revenue Next Year | N/A | $9.73 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.11 | $4.72 |
| 52 Week High | $3.50 | $13.74 |
Technical Indicators
Market Signals| Indicator | PSEC | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 40.09 | 76.46 |
| Support Level | $2.11 | $11.49 |
| Resistance Level | $2.95 | $12.60 |
| Average True Range (ATR) | 0.08 | 0.53 |
| MACD | 0.01 | 0.20 |
| Stochastic Oscillator | 43.21 | 97.78 |
Price Performance
Historical ComparisonAbout PSEC Prospect Capital Corporation
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests mainly in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.